Comparison of infection risks and clinical outcomes in patients with and without SARS‐CoV‐2 lung infection under renin–angiotensin–aldosterone system blockade: Systematic review and meta‐analysis

AIMS: Angiotensin‐converting enzyme‐2 (ACE2) is the receptor for SARS‐CoV‐2. Animal studies suggest that renin–angiotensin–aldosterone system (RAAS) blockers might increase the expression of ACE2 and potentially increase the risk of SARS‐CoV‐2 infection. METHODS AND RESULTS: The effect of ACE inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Chang, Zeng, Shufei, Hasan, Ahmed A., Hocher, Carl‐Friedrich, Krämer, Bernhard K., Hocher, Berthold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Systematic Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753617/
https://www.ncbi.nlm.nih.gov/pubmed/33217033
http://dx.doi.org/10.1111/bcp.14660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753617/
https://www.ncbi.nlm.nih.gov/pubmed/33217033
http://dx.doi.org/10.1111/bcp.14660

Ejemplares similares